SS

Active Director Designated Partner DIN 10135274
DIN 10135274 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Smit Shah

Data last updated:

Smit Shah is a Designated Partner at Elixir Biopharma Llp (since 2023) and Director at Elixir Api Sciences Private Limited (since 2023). The companies operate in Paper.

DIN 10135274
Primary Designation Designated Partner
Industry Paper
First Appointment 26 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Sep 20232023Active
Elixir Api Sciences Private Limited U21002MP2023PTC065472
Director26 Apr 20232023Active

Board colleagues of Smit Shah

Directorship timeline

Open interactive timeline →
Elixir Biopharma Llp
Elixir Api Sciences Private Limited
Premium access

Shareholding and investment profile for Smit Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smit Shah

Smit Shah currently holds 2 directorships: Elixir Biopharma Llp (Designated Partner, since 06 Sep 2023); Elixir Api Sciences Private Limited (Director, since 26 Apr 2023).

Smit Shah was first appointed on 26 Apr 2023 as Director at Elixir Api Sciences Private Limited.

The current boards of Smit Shah's companies include Jayesh Gujarati (Elixir Biopharma Llp), Vivek Kumar Dammani (Elixir Biopharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available